MedPath

A Clinical Study to evaluate the effect of Bilvaadi Panchmula Churna (Anti Obesity Drug of Ayurveda) in Hypothyroidism linked Obesity

Phase 3
Conditions
Health Condition 1: E039- Hypothyroidism, unspecifiedHealth Condition 2: E039- Hypothyroidism, unspecified
Registration Number
CTRI/2022/06/042964
Lead Sponsor
Dr Nellufar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Fresh Diagnosed cases (within 3 Months)

2. Patients with hypothyroidism with features under subjective criteria including

obesity

3. Patients with raised serum TSH, & subnormal T3 & T4 levels along with altered BMI & Waist Hip Ratio

4. patients ready to give consent and participate in the study by following the instructions

Exclusion Criteria

1. Complicated cases of Hypothyroidism or associated with other endocrine disorders

2. Patients with Euthyroidism, hyperthyroidism, Diabetes Mellitus

3. Pregnant & Lactating Patients

4. Patients associated with any other systemic illness

5. patients who fail to give consent

6. patients who have taken antibiotic therapy for any systemic illness within past 2 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thyroid Profile <br/ ><br>Body Mass Index <br/ ><br>Waist Hip RatioTimepoint: Before & after the completion of 3 month drug intervention
Secondary Outcome Measures
NameTimeMethod
association between hypothyroidism & obesityTimepoint: after the completion of 3 month drug intervention in both the groups
© Copyright 2025. All Rights Reserved by MedPath